Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

CHU de Toulouse-Institut Universitaire du Cancer de Toulouse Oncople

2 abstracts

Abstract
Updated efficacy and safety data from the AGILE study in patients with newly diagnosed acute myeloid leukemia treated with ivosidenib + azacitidine compared to placebo + azacitidine.
Org: Institut Gustave Roussy, Hospital Universitario y Politecnico La Fe, ICO-Hospital Germans Trias i Pujol, Medical University of Gdansk, Peking Union Medical College Hospital, Academy of Medical Sciences & Peking Union Medical College, Beijing, China,
Abstract
Preliminary results of a phase 1, first-in-human study of INA03, an anti-CD71 antibody-drug conjugate, in patients with relapsed or refractory (R/R) acute leukemias.
Org: Institut Paoli-Calmettes, Marseille, France, Aix-Marseille University CHU Timone, Marseille, France, Institut Universitaire du Cancer Toulouse, Toulouse, France,